Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Virus and Host
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1502770

ZIKV prM Hijacks PIM1 Kinase for Phosphorylation to Prevent Ubiquitin-Mediated Degradation and Facilitate Viral Replication

Provisionally accepted
  • 1 College of Life Sciences, Wuhan University, Wuhan, China
  • 2 Hubei University of Technology, Wuhan, Hubei Province, China
  • 3 University of Macau, Taipa, Macau Region, China

The final, formatted version of the article will be published soon.

    Viral infection usually stimulates a variety of host cell factors to modulate the life cycle of the virus. PIM1, a serine/threonine protein kinase widely involved in cell proliferation, survival, differentiation and apoptosis, was recently reported to be upregulated by Zika virus (ZIKV) infection. However, how ZIKV-PIM1 interactions affect the viral life cycle are not fully understood. Here, we demonstrated that ZIKV replication was suppressed by the PIM1 kinase inhibitor SGI-1776 in both wt and Ifnar1 -/-murine peritoneal macrophages, indicating that PIM1 functions independently of type I IFN signaling. Coimmunoprecipitation and GST pull-down assays revealed that the ZIKV structural protein precursor membrane (prM) interacted with PIM1. Moreover, we found that prM protein stability was enhanced by PIM1, which was attributed to its kinase activity.Mechanistically, we revealed that prM can undergo ubiquitin-mediated proteolysis and the E3 ubiquitin ligase AMFR can target prM for degradation. Importantly, PIM1 catalyzed phosphorylation of prM at Ser101 and Thr107, and this phosphorylation prevented the proteasome-dependent degradation of prM by impairing its association with AMFR. Therefore, the S101/T107-D phosphorylation mimic mutant of prM was more resistant to PIM1-induced increases in cellular abundance. Together, these findings revealed PIM1 as a critical host factor that is advantageous to ZIKV and revealed that targeting the PIM1-prM axis is a conducive strategy for controlling ZIKV infection.

    Keywords: ZIKV, PRM, PIM1, Phosphorylation, Ubiquitination

    Received: 27 Sep 2024; Accepted: 13 Nov 2024.

    Copyright: © 2024 Ren, Liu, Pang, Xu, Lei, Kwok, Wu and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Zhijian Cao, College of Life Sciences, Wuhan University, Wuhan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.